Can-Fite BioPharma (CANF) Shares Outstanding (Diluted) (2020 - 2026)
Can-Fite BioPharma (CANF) posted Weighted Average Shares Outstanding (Diluted) of 823,104 for Q2 2026, down 98.5% from 54.4 million a year earlier.
Can-Fite BioPharma (CANF) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Since Q4 2020, Can-Fite BioPharma has reported Weighted Average Shares Outstanding (Diluted) for 18 quarters.
- Annual Weighted Average Shares Outstanding (Diluted) shows a five-year compound annual growth rate of -38.0% (FY2020 to FY2025).
- In prior years, Can-Fite BioPharma's Weighted Average Shares Outstanding (Diluted) was 54.4 million in FY2024 (+70.2%), 31.96 million in FY2023 (+56.7%), 20.39 million in FY2022 (+47.5%) and 13.83 million in FY2021 (+54.3%).
- Quarterly Weighted Average Shares Outstanding (Diluted) has run from a low of 823,104 in Q4 2025 to a high of 54.4 million in Q2 2025 over five years.
- On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) increased in two of the last four quarters, with an average decline of 14.1%.
- The strongest year-over-year quarter for Weighted Average Shares Outstanding (Diluted) in the past five years was Q2 2025, with growth of 70.2%; the weakest was Q4 2025, with a decline of 98.5%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Can-Fite BioPharma | 2.16 Mn | -17.54 Mn | - | 823,104.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 823,104.00 |
| Dec 31, 2025 | 823,104.00 |
| Jun 30, 2025 | 54.40 Mn |
| Dec 31, 2024 | 54.40 Mn |
| Jun 30, 2024 | 31.96 Mn |
| Dec 31, 2023 | 31.96 Mn |
| Sep 30, 2023 | 20.39 Mn |
| Jun 30, 2023 | 20.39 Mn |
| Mar 31, 2023 | 20.39 Mn |
| Dec 31, 2022 | 20.39 Mn |
| Sep 30, 2022 | 13.83 Mn |
| Jun 30, 2022 | 13.83 Mn |
| Mar 31, 2022 | 13.83 Mn |
| Dec 31, 2021 | 13.83 Mn |
| Sep 30, 2021 | 8.96 Mn |
| Jun 30, 2021 | 8.96 Mn |
| Mar 31, 2021 | 8.96 Mn |
| Dec 31, 2020 | 8.96 Mn |
Can-Fite BioPharma Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CANF&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();